Opening Bell Report

Investors picked up blue chip stocks following an upbeat job creation report and an increase in November factory orders. The Dow rose 60 points to 13,104 while Nasdaq added a point to 2611.

On the upside

Sciele Pharma (Nasdaq: SCRX) received FDA approval to sell a new version of its high blood pressure drug treatment.

Seed company Monsanto (NYSE: MON) posted earnings that tripled citing strong Latin American results.

Investors continued to snap up shares of Akeena Solar (Nasdaq: AKNS) which traded at new highs.

On the downside

Shares of CVS Caremark (NYSE: CVS) lost ground after the drugstore chain operator updated its outlook toward the low end of analysts' expectations.

The sell-off in the chip sector continued with shares of Intel (Nasdaq: INTC) and Advanced Micro Devices (NYSE: AMD) losing ground for a 2nd day in a row.

Bakery and cafe chain Panera Bread (Nasdaq: PNRA) posted higher revenues, but unfavorable weather conditions hurt same-store sales results.

In the broad market, advancing issues outpaced decliners by a margin of nearly 2 to 1 on the NYSE and by a slim margin on Nasdaq. The Russell 2000 which tracks small cap stocks added 2 points to 756.

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here